260 related articles for article (PubMed ID: 15161358)
21. A-bomb survivors: factors that may lead to a re-assessment of the radiation hazard.
Stewart AM; Kneale GW
Int J Epidemiol; 2000 Aug; 29(4):708-14. PubMed ID: 10922349
[TBL] [Abstract][Full Text] [Related]
22. Radiation dose-response relationships for thyroid nodules and autoimmune thyroid diseases in Hiroshima and Nagasaki atomic bomb survivors 55-58 years after radiation exposure.
Imaizumi M; Usa T; Tominaga T; Neriishi K; Akahoshi M; Nakashima E; Ashizawa K; Hida A; Soda M; Fujiwara S; Yamada M; Ejima E; Yokoyama N; Okubo M; Sugino K; Suzuki G; Maeda R; Nagataki S; Eguchi K
JAMA; 2006 Mar; 295(9):1011-22. PubMed ID: 16507802
[TBL] [Abstract][Full Text] [Related]
23. Cancer and non-cancer effects in Japanese atomic bomb survivors.
Little MP
J Radiol Prot; 2009 Jun; 29(2A):A43-59. PubMed ID: 19454804
[TBL] [Abstract][Full Text] [Related]
24. Impact on the Japanese atomic bomb survivors of radiation received from the bombs.
Cullings HM
Health Phys; 2014 Feb; 106(2):281-93. PubMed ID: 24378504
[TBL] [Abstract][Full Text] [Related]
25. High Initial-dose Dependency of Cerebrovascular Disease Mortality among Female Survivors of the Hiroshima Atomic Bomb Exposed in Teens: A Cohort Study, 1970-2010.
Matsuba J; Otani K; Satoh K; Kawakami H; Ohtaki M
Hiroshima J Med Sci; 2016 Sep; 65(2):35-43. PubMed ID: 29989683
[TBL] [Abstract][Full Text] [Related]
26. Dose response and temporal patterns of radiation-associated solid cancer risks.
Preston DL; Pierce DA; Shimizu Y; Ron E; Mabuchi K
Health Phys; 2003 Jul; 85(1):43-6. PubMed ID: 12852470
[TBL] [Abstract][Full Text] [Related]
27. Radiation dose associated with renal failure mortality: a potential pathway to partially explain increased cardiovascular disease mortality observed after whole-body irradiation.
Adams MJ; Grant EJ; Kodama K; Shimizu Y; Kasagi F; Suyama A; Sakata R; Akahoshi M
Radiat Res; 2012 Feb; 177(2):220-8. PubMed ID: 22149958
[TBL] [Abstract][Full Text] [Related]
28. Effect of radiation dose on the height of atomic bomb survivors: a longitudinal study.
Nakashima E; Fujiwara S; Funamoto S
Radiat Res; 2002 Sep; 158(3):346-51. PubMed ID: 12175312
[TBL] [Abstract][Full Text] [Related]
29. Radiation dose and cataract surgery incidence in atomic bomb survivors, 1986-2005.
Neriishi K; Nakashima E; Akahoshi M; Hida A; Grant EJ; Masunari N; Funamoto S; Minamoto A; Fujiwara S; Shore RE
Radiology; 2012 Oct; 265(1):167-74. PubMed ID: 22875798
[TBL] [Abstract][Full Text] [Related]
30. Risk of death among children of atomic bomb survivors after 62 years of follow-up: a cohort study.
Grant EJ; Furukawa K; Sakata R; Sugiyama H; Sadakane A; Takahashi I; Utada M; Shimizu Y; Ozasa K
Lancet Oncol; 2015 Oct; 16(13):1316-23. PubMed ID: 26384241
[TBL] [Abstract][Full Text] [Related]
31. A pathology study of malignant and benign ovarian tumors among atomic-bomb survivors--case series report.
Inai K; Shimizu Y; Kawai K; Tokunaga M; Soda M; Mabuchi K; Land CE; Tokuoka S
J Radiat Res; 2006 Mar; 47(1):49-59. PubMed ID: 16571918
[TBL] [Abstract][Full Text] [Related]
32. A long-term cohort study of the atomic-bomb survivors.
Kodama K; Mabuchi K; Shigematsu I
J Epidemiol; 1996 Aug; 6(3 Suppl):S95-105. PubMed ID: 8800280
[TBL] [Abstract][Full Text] [Related]
33. Flexible dose-response models for Japanese atomic bomb survivor data: Bayesian estimation and prediction of cancer risk.
Bennett J; Little MP; Richardson S
Radiat Environ Biophys; 2004 Dec; 43(4):233-45. PubMed ID: 15565453
[TBL] [Abstract][Full Text] [Related]
34. Corrections in the atomic bomb data to examine low dose risk.
Baker GS; Hoel DG
Health Phys; 2003 Dec; 85(6):709-20. PubMed ID: 14626322
[TBL] [Abstract][Full Text] [Related]
35. Cancer risk estimates from the combined Japanese A-bomb and Hodgkin cohorts for doses relevant to radiotherapy.
Schneider U; Walsh L
Radiat Environ Biophys; 2008 Apr; 47(2):253-63. PubMed ID: 18157543
[TBL] [Abstract][Full Text] [Related]
36. Absence of evidence for differences in the dose-response for cancer and non-cancer endpoints by acute injury status in the Japanese atomic-bomb survivors.
Little MP
Int J Radiat Biol; 2002 Nov; 78(11):1001-10. PubMed ID: 12456287
[TBL] [Abstract][Full Text] [Related]
37. Risk factors for primary breast cancer in Japan: 8-year follow-up of atomic bomb survivors.
Goodman MT; Cologne JB; Moriwaki H; Vaeth M; Mabuchi K
Prev Med; 1997; 26(1):144-53. PubMed ID: 9010910
[TBL] [Abstract][Full Text] [Related]
38. Selection of reference groups in the Life Span Study of atomic bomb survivors.
French B; Cologne J; Sakata R; Utada M; Preston DL
Eur J Epidemiol; 2017 Dec; 32(12):1055-1063. PubMed ID: 29204903
[TBL] [Abstract][Full Text] [Related]
39. Studies of mortality of atomic bomb survivors. Report 13: Solid cancer and noncancer disease mortality: 1950-1997.
Charles MW
J Radiol Prot; 2003 Dec; 23(4):457-9. PubMed ID: 14750694
[No Abstract] [Full Text] [Related]
40. Radiation dose response estimation with emphasis on low dose range using restricted cubic splines: application to all solid cancer mortality data, 1950-2003, in atomic bomb survivors.
Nakashima E
Health Phys; 2015 Jul; 109(1):15-24. PubMed ID: 26011495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
